Preference Tx for Sequencing in NSCLC
Research Grant
Administered By
Duke Clinical Research Institute
Awarded By
AstraZeneca Pharmaceuticals, LP
Start Date
August 24, 2018
End Date
March 31, 2021
Administered By
Duke Clinical Research Institute
Awarded By
AstraZeneca Pharmaceuticals, LP
Start Date
August 24, 2018
End Date
March 31, 2021